- Report
- November 2021
- 1184 Pages
Global
From €5686EUR$6,000USD£4,798GBP
- Report
- May 2022
- 205 Pages
Global
From €3275EUR$3,456USD£2,764GBP
- Book
- May 2022
- 512 Pages
- Book
- March 2022
- 896 Pages
- Book
- October 2020
- 288 Pages
- Book
- September 2012
- 688 Pages
- Book
- April 2010
- 512 Pages
- Book
- November 2008
- 496 Pages
- Book
- June 2023
- 448 Pages
- Book
- August 2024
Global

The MicroRNA market is a subset of the genomics industry that focuses on the study of small, non-coding RNA molecules. MicroRNAs are involved in a variety of biological processes, including gene expression, development, and disease. They are increasingly being studied as potential therapeutic targets for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.
The market for microRNA-based therapeutics is growing rapidly, driven by advances in sequencing technology and the development of new delivery systems. Companies are developing a variety of products, including diagnostics, therapeutics, and research tools.
Some of the major players in the microRNA market include Thermo Fisher Scientific, Illumina, Qiagen, Merck, and Novartis. Other companies, such as Exiqon, Bio-Rad, and Bio-Techne, are also active in the market. Show Less Read more